undamentalytics Newsletter
Sign in

Cerus Corp revenue

Cerus Corp's revenue was $234m in fiscal 2025, up 16.1% on the year before. Since fiscal 2009 ($18.0m) it has grown at a compound 17.4% a year. Over the last twelve months it was $254m.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2009Dec 20092010Dec 20102011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMSept 2026
Revenue1823333740363439517694114160188187201234254
Growth on the year before—+28.5%+43.0%+11.3%+7.8%−8.2%−6.0%+14.8%+30.7%+48.2%+23.3%+21.8%+39.6%+18.1%−0.8%+7.8%+16.1%—
Gross profit51012161715111729446073——————
Gross margin30.0%41.7%36.5%43.7%43.0%41.8%31.4%43.0%56.1%58.4%64.4%64.0%——————

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Where the revenue comes from

Fiscal year to December 31, 2025
Products and services
Line of business Revenue Share YoY
Products $206M 88.2% ▲ 14.3%
Government Contract $27.7M 11.8% ▲ 31.4%

From Cerus Corp's 10-K filed March 2, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Revenue against peers

Health Care Equipment: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Cerus Corp $254m 74.6% 89.8%
Lemaitre Vascular Inc $262m 11.8% 14.0%
Establishment Labs Holdings Inc. $246m 38.6% 11.5%
Orthopediatrics Corp $264m 16.1% 23.0%
Axogen, Inc. $267m 24.3% 20.6%
Skinhealth Systems Inc. $290m -6.5% -9.5%

Compare with peers

Head to head: CERS vs LMATCERS vs ESTACERS vs KIDSAXGN vs CERS

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Cerus Corp's SEC filings (10-K and 10-Q), retrieved November 3, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Cerus Corp.